Biomarkers in Hematology and Oncology

Biomarker is a measurable meter of the severity or presence of some disease state. More generally a biomarker can be used as an indicator of a physiological state or a specific disease of an organism. Biomarkers in hematology are useful to identify or diagnose blood diseases in animals.
Cancer biomarkers are biological molecules formed by the body or tumor in a person with cancer. Biomarker testing helps describe alterations in the tumor. Biomarkers can be DNA, RNA, protein or metabolomics profiles that are definite to the tumor. 

Related Tags: 
  • Hematology Conference
  • Hematology conferences 2024
  • Hematology conferences
  • Hematology conferences 2024
  • Hematology Congress
  • Hematology Congress 2024
  • Hematology meetings
  • Hematology meeting 2024
  • Hematology summit
  • Hematology summit 2024
  • Leukemia conference
  • Leukemia conferences
  • Leukemia conference 2024
  • Leukemia conferences 2024
  • Leukemia congress
  • Leukemia congress 2024
  • Leukemia meeting
  • Leukemia meetings
  • Leukemia meeting 2024
  • Leukemia meetings 2024
  • Leukemia summit
  • Leukemia summit 2024
  • Lymphoma congress
  • Lymphoma congress 2024
  • Lymphoma summit
  • Lymphoma summit 2024
  • Lymphoma meeting
  • Lymphoma meeting 2024
  • Myelofibrosis
  • Myelofibrosis 2024
  • Myelofibrosis congress
  • Myelofibrosis congress 2024
Related Associations: 
  • American Academy of Hospice and Palliative Medicine
  • American Association for Cancer Education
  • Australasian Society of Blood Transfusion
  • Austrian Society of Hematology and Oncology
  • Croatian Hematology and Blood Transfusion Society
  • Cyprus Society of Haematology
  • Ceská Hematologická Spolecnost CLS JEP

 

Submit Abstract